Stem cell startup in global rollout – Business Weekly
|
Stem cell startup in global rollout
Business Weekly Axol's proprietary brain stem cells are produced from reprogrammed human blood cells, known as iPS cells, and the new distribution network will manage sales and support in the US, Japan, Scandinavia and several territories in mainland Europe including … |
